相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Multi-Criteria Decision Analysis to Develop an Efficacy-Safety Profile of Parenteral Analgesics Used in the Treatment of Postoperative Pain
Stephan Schug et al.
JOURNAL OF PAIN RESEARCH (2020)
Multicriteria Decision Analysis Applied to the Clinical Use of Pharmacotherapy for Overactive Bladder Symptom Complex
Christopher R. Chapple et al.
EUROPEAN UROLOGY FOCUS (2020)
Benefit-risk Assessment of Cladribine Using Multi-criteria Decision Analysis (MCDA) for Patients With Relapsing-remitting Multiple Sclerosis
Patrick Vermersch et al.
CLINICAL THERAPEUTICS (2019)
Luxturna: FDA documents reveal the value of a costly gene therapy
Jonathan J. Darrow
DRUG DISCOVERY TODAY (2019)
Benefit-Risk Assessments at the US Food and Drug Administration Finding the Balance
Robert M. Califf
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Use of multicriteria decision analysis for assessing the benefit and risk of over-the-counter analgesics
Andrew Moore et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2017)
Approving a Problematic Muscular Dystrophy Drug Implications for FDA Policy
Aaron S. Kesselheim et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Value-Based Assessment of New Medical Technologies: Towards a Robust Methodological Framework for the Application of Multiple Criteria Decision Analysis in the Context of Health Technology Assessment
Aris Angelis et al.
PHARMACOECONOMICS (2016)
Recommendations for benefit-risk assessment methodologies and visual representations
Diana Hughes et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2016)
Multiple Criteria Decision Analysis for Health Care Decision Making-Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force
Kevin Marsh et al.
VALUE IN HEALTH (2016)
Cognitive and Motivational Biases in Decision and Risk Analysis
Gilberto Montibeller et al.
RISK ANALYSIS (2015)
Risk Attitudes and Personality Traits Predict Perceptions of Benefits and Risks for Medicinal Products: A Field Study of European Medical Assessors
Andrea R. Beyer et al.
VALUE IN HEALTH (2015)
Modelling the risk-benefit impact of H1N1 influenza vaccines
Lawrence D. Phillips et al.
EUROPEAN JOURNAL OF PUBLIC HEALTH (2013)
Surrogate Outcomes in Clinical Trials A Cautionary Tale
Staffan Svensson et al.
JAMA INTERNAL MEDICINE (2013)
Decision analysis of retrievable inferior vena cava filters in patients without pulmonary embolism
Jose Pablo Morales et al.
Journal of Vascular Surgery-Venous and Lymphatic Disorders (2013)
Reputation and Precedent in the Bevacizumab Decision
Daniel Carpenter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Facilitated modelling in operational research
L. Alberto Franco et al.
EUROPEAN JOURNAL OF OPERATIONAL RESEARCH (2010)
Measuring Benefit and Balancing Risk: Strategies for the Benefit-Risk Assessment of New Medicines in a Risk-Averse Environment
S. Walker et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Safe Drugs and the Cost of Good Intentions
Hans-Georg Eichler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)